Medical specialists from United Kingdom tagged as investigators in clinical trials studying Carcinoma, Non-Small-Cell Lung
Total 115 results
-
Adam HassaniSeen in:
- Newcastle Upon Tyne, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
Trials:- NCT04550104 (Principal Investigator)
Conditions: -
Alastair Greystoke, DrSeen in:
- Newcastle, Freeman Hospital
- Newcastle, Great North Children's Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Alex Dr MartinSeen in:
- Cambridge, Addenbrooke's Hospital
Trials:- NCT02417662 (Principal Investigator)
Conditions: -
Andreas PolychronisSeen in:
- Hillingdon, Northwood, Mount Vernon Hospital
- Middlesex, Northwood, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Andrew Dr BatesSeen in:
- Southampton, Southampton General Hospital
Trials:- NCT02417662 (Principal Investigator)
Conditions: -
Andrew DuncanSeen in:
- Aberdeen City, Aberdeen, Aberdeen Royal Infirmary
Trials:- NCT06119581 (Principal Investigator)
Conditions: -
Angel Garcia-AlonsoSeen in:
- Denbighshire, Bodelwyddan, Betsi Cadwaladr University Health Board - Glan Clwyd District General Hospital
- Wrexham, GSK Investigational Site
Trials:- NCT04475939 (Principal Investigator)
- NCT02834884 (Principal Investigator)
Conditions: -
Anja WilliamsSeen in:
- London, Sarah Cannon Research Institute UK
Trials:- NCT05104515 (Principal Investigator)
Conditions: -
Ankit JainSeen in:
- West Midlands, Wolverhampton, GSK Investigational Site
- West Midlands, Wolverhampton, New Cross Hospital
- Wolverhampton, New Cross Hospital
Trials:- NCT04819100 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Anna MinchomSeen in:
- England, London, Royal Marsden Hosital, Sutton
- London, Royal Marsden Hospital
- Other, London, The Royal Marsden NHS Foundation Trust (RM)
- Other, Surrey, The Royal Marsden Hospital
- Other, Sutton, The Royal Marsden Hospital (Surrey)
- Surrey, Sutton, Royal Marsden Hospital
- Surrey, The Royal Marsden Hospital
- Sutton, Royal Marsden Hospital
- Sutton, The Royal Marsden Hospital (Surrey)
Trials:- NCT03157128 (Principal Investigator)
- NCT04254107 (Principal Investigator)
- NCT04665921 (Principal Investigator)
- NCT04042480 (Principal Investigator)
- NCT05229900 (Principal Investigator)
- NCT05208762 (Principal Investigator)
- NCT05782361 (Principal Investigator)
- NCT05074810 (Principal Investigator)
Conditions:- Non-Small Cell Lung Cancer;
- Colon Cancer;
- Medullary Thyroid Cancer;
- Any Solid Tumor;
- Cervical Cancer;
- Ovarian Cancer;
- Peripheral T-cell Lymphoma;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Gastric Carcinoma;
- Classical Hodgkin Lymphoma;
- Diffuse Large B-cell Lymphoma;
- Cutaneous Melanoma;
- Gastroesophageal Junction Carcinoma;
- Uterine Cervical Neoplasms;
- Stomach Neoplasms;
- Colorectal Neoplasms;
- Esophageal Neoplasms;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Pseudomyxoma Peritonei;
- Carcinoma, Non-Small Cell Lung;
- HER2 Negative Breast Neoplasms;
- Exocrine Pancreatic Adenocarcinoma;
- Appendiceal Adenocarcinoma;
- Colorectal Cancer;
- Pancreatic Ductal Adenocarcinoma;
- Pleural Mesothelioma;
- Testicular Neoplasms;
- Carcinoma, Non-Small-Cell Lung;
- Melanoma;
- Gastric Cancer;
- Squamous Cell Carcinoma of the Head and Neck;
- Triple Negative Breast Neoplasms;
- Esophageal Squamous Cell Carcinoma;
- Non Small Cell Lung Cancer;
- Advanced Cancer;
- KRAS Activating Mutation
-
Anne Thomas, DrSeen in:
- Leicester, Leicester Royal Infirmary
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Anthony PopeSeen in:
- Wirral, Clatterbridge
- Wirral, Clatterbridge Cancer Centre
Trials:- NCT02040272 (Principal Investigator)
- NCT02417662 (Principal Investigator)
Conditions: -
Antony Ng, DrSeen in:
- Bristol, Bristol Haematology and Oncology Centre
- Bristol, Bristol Royal Hospital for Children
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Babu NaiduSeen in:
- Birmingham, Heart of England NHS Foundation Trust
Trials:- NCT01888601 (Principal Investigator)
Conditions: -
Bristi Basu, DrSeen in:
- Cambridge, Addenbrooke's Hospital
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Carles Escriu, MD, PhDSeen in:
- Wirral, The Clatterbridge Cancer Centre
Trials:- NCT05127590 (Principal Investigator)
Conditions: -
Charles SwantonSeen in:
- Select Region, London, University College London Hospitals NHS Foundation Trust
Trials:- NCT01888601 (Principal Investigator)
Conditions: -
Christian OttensmeierSeen in:
- Hampshire, Southampton, University Hospital Southampton NHS Foundation Trust
- Lancashire, Liverpool, The Clatterbridge Cancer Centre NHS Foundation Trust
- Southampton, Cancer Research UK Centre, Southampton University Hospitals and University of Southampton
Trials:- NCT05043714 (Principal Investigator)
- NCT01888601 (Principal Investigator)
- NCT02758587 (Principal Investigator)
-
Clara ChanSeen in:
- Manchester, The Christie NHS Foundation Trust
Trials:- NCT04550104 (Principal Investigator)
Conditions: -
Colin Barrie, MDSeen in:
- Edinburgh, Edinburgh Cancer Centre
- Scotland, Edinburgh, Edinburgh Cancer Centre - 2809
Trials:- NCT05384626 (Principal Investigator)
- NCT05671510 (Principal Investigator)
-
Colin LindsaySeen in:
- Manchester, The Christie NHS Foundation Trust
- Withington, Manchester, The Christie NHS Foundation Trust
Trials:- NCT02834884 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions: -
Corinne Dr Faivre-FinnSeen in:
- Manchester, Christie Hospital
Trials:- NCT02417662 (Principal Investigator)
Conditions: -
Corinne Faivre-FinnSeen in:
- Greater Manchester, Manchester, The Christie NHS Foundation Trust
- Manchester, The Christie Hospital
- Manchester, The Christie NHS Foundation Trust
Trials:- NCT04550104 (Principal Investigator)
- NCT03645317 (Principal Investigator)
- NCT03256981 (Principal Investigator)
- NCT02123888 (Principal Investigator)
- NCT06086574 (Principal Investigator)
Conditions: -
Crispin HileySeen in:
- London, University College Hospital London
- London, University College London Hospital
Trials:- NCT04550104 (Principal Investigator)
- NCT05655078 (Principal Investigator)
Conditions: -
Dan Palmer, DrSeen in:
- Wirral, Clatterbridge Cancer Centre
Trials:- NCT05722886 (Principal Investigator)
- NCT05768178 (Principal Investigator)
- NCT05770037 (Principal Investigator)
- NCT05770102 (Principal Investigator)
- NCT05770544 (Principal Investigator)
- NCT05786716 (Principal Investigator)
Conditions:- Solid Tumor;
- Haematological Malignancy;
- Glioma;
- Melanoma;
- Carcinoma, Non-Small-Cell Lung;
- Multiple Myeloma;
- Colorectal Neoplasms;
- Ovarian Neoplasms;
- Thyroid Cancer, Papillary;
- Thyroid Carcinoma, Anaplastic;
- Laryngeal Neoplasms;
- Erdheim-Chester Disease;
- Neoplasms by Histologic Type;
- Lymphoma;
- Lymphoproliferative Disorders;
- Neoplasms by Site;
- Renal Cell Carcinoma;
- Cancer;
- Anaplastic Large Cell Lymphoma;
- Neuroblastoma;
- Malignant Neoplasm;
- Endometrial Neoplasms;
- Malignancy;
- Brain Neoplasms;
- Gallbladder Neoplasms;
- Prostatic Neoplasm;
- Pancreatic Neoplasm;
- Lung Neoplasm;
- Urinary Bladder Neoplasm;
- Skin Neoplasm;
- Salivary Gland Neoplasm
-
Daniel J HughesSeen in:
- London, Guy's and St Thomas' NHS Foundation Trust
Trials:- NCT04436406 (Sub-Investigator)
Conditions: -
David Pinato, MD, PhDSeen in:
- London, Imperial College London
Trials:- NCT05127590 (Principal Investigator)
Conditions: -
Dean Fennell, ProfSeen in:
- Leicester, Department of Cancer Studies, University of Leicester, Leicester Royal Infirmary
Trials:- NCT02758587 (Principal Investigator)
Conditions:
Clinical Trials on Carcinoma, Non-Small-Cell Lung
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage I Non-Small Cell Lung Cancer | Stage II Non-Small Cell Lung Cancer | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung Carcinoma | Non-Squamous Non-Small...United States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Society of Thoracic RadiologyActive, not recruitingStage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage I Lung Non-Small Cell Cancer AJCC v7 | Stage...United States
-
National Cancer Institute (NCI)Active, not recruitingStage IIIA Lung Non-Small Cell Cancer AJCC v7 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC...United States